Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (42)

2023

  1. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

  2. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

  3. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 5, pp. 225-228

  2. Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study

    Frontiers in Pediatrics, Vol. 10

  3. Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children

    European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115

  4. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  5. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

    Journal of Pediatrics, Vol. 241, pp. 126-132.e3

  6. Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children

    Acta Paediatrica, International Journal of Paediatrics, Vol. 111, Núm. 10, pp. 1974-1977

  7. Oral Versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom?

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 9, pp. E351-E357

  8. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

    Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058

  9. Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study

    Thorax, Vol. 77, Núm. 12, pp. 1193-1201

  10. Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 10, pp. 471-473

  11. Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

    The Pediatric infectious disease journal, Vol. 41, Núm. 5, pp. e235-e242

  12. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. A Bayesian Model to Predict COVID-19 Severity in Children

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 8, pp. E287-E293

  2. COVID-19 pandemic. What have we learned?

    Anales de Pediatria, Vol. 95, Núm. 5, pp. 382.e1-382.e8

  3. Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population

    Journal of Pediatrics, Vol. 232, pp. 287-289.e4

  4. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2099-2106

  5. Low COVID-19 mortality in Spanish children

    The Lancet Child and Adolescent Health